BRIEF published on 02/20/2024 at 13:00, 2 years 6 months ago Yunu révolutionne l'écosystème d'imagerie dans les essais cliniques Technologie Imagerie Médicale Yunu Essais Cliniques Recherche En Oncologie
PRESS RELEASE published on 11/15/2023 at 16:00, 2 years 9 months ago Yunu Integration to Florence Improves Imaging Accuracy and Workflow Efficiency
PRESS RELEASE published on 03/28/2023 at 14:00, 3 years 5 months ago Yunu Opens the Yunuverse, Increasing Trial Access for Patients and Solving Staffing Challenges for Cancer Centers, Pharma, and CRO Customers
Published on 09/11/2026 at 23:00, 1 hour 30 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 2 hours 25 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 3 hours 5 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 7 hours 30 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/11/2026 at 17:00, 7 hours 30 minutes ago Critical Elements sélectionné pour inclusion dans le prospectus du sommet Canadien de l'investissement, mettant le projet en valeur auprès d'investisseurs mondiaux de premier plan
Published on 09/11/2026 at 22:15, 2 hours 15 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 2 hours 19 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 4 hours 45 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 6 hours 14 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 17 hours 30 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 17 hours 30 minutes ago Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 17 hours 30 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 17 hours 30 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 5 hours ago Availability of the 2026 Interim Financial Report
